Week7, 2021
1. Influenza activity in the U.S. remains below normal levels for this time of year, with only 0.1% of respiratory specimens testing positive for influenza in clinical labs.
2. Clinical labs reported 28 positive specimens, with 46.4% Influenza A and 53.6% Influenza B.
3. Public health labs reported only 2 positive specimens, all Influenza A, but no further subtyping was conducted.
4. Nationwide, 1.0% of outpatient visits were for influenza-like illness (ILI), unchanged from last week and well below the national baseline of 2.6%.
5. The cumulative hospitalization rate is 0.6 per 100,000 population, substantially lower than prior low-severity seasons.
6. Deaths attributed to pneumonia, influenza, or COVID-19 (PIC) comprised 19.3%, exceeding the epidemic threshold, but most were due to COVID-19.
7. No influenza-associated pediatric deaths were reported this week, maintaining the season total at one.
8. Flu vaccination is encouraged, but no specific trends or data on vaccination rates were provided.
9. Healthcare-seeking behaviors and ILI surveillance are impacted by the COVID-19 pandemic, requiring cautious interpretation of ILI data.
10. CDC highlights the unpredictability of future influenza activity and advises monitoring, particularly given concurrent COVID-19 trends.

11. Additional relevant details:
12. - Minimal ILI activity was reported across all U.S. jurisdictions this week.
13. - Slight increasing ILI trends were observed in children aged 0â€“4 years over the past six weeks, while older age groups showed slight decreases.
14. - Virological characterization and additional hospitalization data will be updated later in the season as more cases are reported.